Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 1Phase 3 1

Status

Completed 9Terminated 7Recruiting 7Unknown 3Not yet recruiting 3Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 2Dermatologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 2Hemangioma 2Melanoma 1Hemangioma, Cavernous, Central Nervous System 1Breast Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Propranolol × Clear all
NCT03152786 2025-02-17

Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Wake Forest University Health Sciences

Phase 2 Terminated
46 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT03474614 2024-04-19

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

St. Joseph's Hospital and Medical Center, Phoenix

Phase 2 Terminated
4 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

NCT01074437 2018-10-04

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Seattle Children's Hospital

Phase 2 Terminated
9 enrolled 5 charts

Hemangioma

NCT01857817 2018-04-26

Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer

Vicus Therapeutics

Phase 2 Terminated
35 enrolled
Genitourinary

Prostatic Neoplasms

NCT02596867 2018-03-01

NPBC

Texas Tech University Health Sciences Center, El Paso

Phase 2 Terminated
2 enrolled 5 charts
Breast

Breast Neoplasms

NCT01705392 2017-02-24

Bevacizumab vs Dacarbazine in Metastatic Melanoma

Haukeland University Hospital

Phase 2 Terminated
2 enrolled
Dermatologic

Melanoma

NCT00967226 2016-02-24

Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas

Children's National Research Institute

Phase 2 Terminated
19 enrolled 25 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡